| 发明名称 |
Method for determining the risk of toxicity of sorafenib in cancer patients |
| 摘要 |
<p>The present invention relates to a method for determining the risk of toxicity of sorafenib in cancer patients, based on the polymorphism of the UGT1A9 gene, and in particular the presence of the UGT1A9 -2152 C>T Single Nucleotide Polymorphism.</p> |
| 申请公布号 |
EP2666869(A1) |
申请公布日期 |
2013.11.27 |
| 申请号 |
EP20120169495 |
申请日期 |
2012.05.25 |
| 申请人 |
UNIVERSITE PARIS DESCARTES |
发明人 |
BLANCHET, BENOIT;NARJOZ, CELINE;BOUDOU-ROUQUETTE, PASCALINE;LORIOT, MARIE-ANNE |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
